drugset / Trial / NCT03033121

Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

NCT03033121

Phase 3 Completed 32 enrolled University of Palermo
RandomizedParallel-groupOpen-labelTreatment

Summary

Growth hormone (GH) treatment in patients with GH deficiency (GHD) is commonly administered daily, although the pulsatile GH secretion is unlikely to be achieved and this regimen is often not complied. The auxological effect of three injections per week (TIW) regimen is controversial, while the metabolic effects were never evaluated in children. The objective of this study was to evaluate whether two different regimens of weekly injections could lead to similar auxological and metabolic effects in children with GHD.

Timeline

Start
2016-01-01
Primary completion
2017-01-01
Completion
2017-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.2 mg/kg

Indications

No indication recorded.